CochLear Ltd. Unsponsored ADR (OTCMKTS:CHEOY – Get Free Report)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $66.48 and last traded at $67.13, with a volume of 873 shares. The stock had previously closed at $70.60.
Wall Street Analysts Forecast Growth
Separately, Royal Bank Of Canada raised CochLear from a “hold” rating to a “moderate buy” rating in a research report on Monday, January 19th. Two investment analysts have rated the stock with a Strong Buy rating, one has assigned a Buy rating and two have given a Hold rating to the company’s stock. According to data from MarketBeat.com, CochLear has a consensus rating of “Buy”.
Check Out Our Latest Stock Analysis on CochLear
CochLear Stock Performance
CochLear Company Profile
Cochlear Limited provides implantable hearing solutions for children and adults worldwide. It offers cochlear implant systems, sound processor upgrades, bone conduction systems, accessories, and other products. Cochlear Limited was founded in 1981 and is headquartered in Sydney, Australia.
Featured Stories
- Five stocks we like better than CochLear
- The gold chart Wall Street is terrified of…
- America’s 1776 happening again
- Buy this Gold Stock Before May 2026
- What a Former CIA Agent Knows About the Coming Collapse
- “Fed Proof” Your Bank Account with THESE 4 Simple Steps
Receive News & Ratings for CochLear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CochLear and related companies with MarketBeat.com's FREE daily email newsletter.
